U.S. Drug Firms Under IRS Scrutiny For Offshore Income Shifting
Executive Summary
U.S.-based drug companies inappropriately reported that foreign profits accounted for 66% of their worldwide profits in 2003-2005, 23% more than the amount calculated by Tax Analysts, according to a publication by the non-profit group